Sponsor Pipeline

TCRx Therapeutics Co.Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
4
Early Phase 1
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07260812 KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Non-Hodgkin Lymphoma Recruiting
NCT07596693 KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) Advanced Solid Tumors Recruiting
NCT07196579 Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors Advanced Solid Cancer Not Yet Recruiting
NCT07275853 Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Early Phase 1
NCT05539833 KSH01-TCRT Solid Tumors TCR-T Cells Recruiting
NCT05580796 KSH01-R02-101 Solid Tumors Solid Tumor Recruiting
NCT05811975 KSX01-TCRT Injection Project in Solid Tumors TCR-T Cells Recruiting
Not specified
NCT07663565 Apheresis Collection for New Drug Development and Evaluation Research PBMCs Recruiting
Disease Areas
Get alerts when TCRx Therapeutics Co.Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free